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Tuesday, November 29, 2022
As the COVID-19 pandemic continues to evolve, we are seeing other emerging public health threats/emergencies and we continue to address
ongoing/emerging disaster issues, the Center for Disaster Medicine (CDM) has been and will continue to be a source of reliable information, education
and models for mitigation, preparedness, response, and recovery. As such we have expanded this informational document to address the broader areas
addressed by the center while retaining critical COVID19 information. As the pace of new information and changes occur, we will evaluate the current
once per week to determine if this information should be provided on a more frequent basis

                                                                                                                       
David Markenson, M.D., M.B.A.
Director, Center for Disaster Medicine

COVID-19 Statistics

Total Cases

Total Deaths

Total Vaccine Doses
Admin.

Worldwide

641,875,850

6,632,356

13,034,703,169

United States

98,630,690

1,079,496

611,686,655

New Jersey

2,843,317

35,093

19,240,352

New York

6,367,505

73,871

43,786,365

Connecticut

925,377

12,572

8,743,711

Information as of 11/29/22 at 0000 EST. Source: https://coronavirus.jhu.edu/map.html

United States COVID-19 Case Map / GIS

Monkey Pox Statistics
State

Number of Cases

Connecticut

143

New Jersey

759

New York

4,165

Total US Case Count

29,288

CDC https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html

Center for Disaster Medicine Updates
Coordinating and overseeing COVID-19 screenings at NYMC campus.
Continuing to partner with local organizations such as Westchester Department of Emergency Services and Westchester Medical
Center to ensure ongoing collaboration with all public safety agencies.
Coordinating volunteers to support local public health response to COVID-19.
Conducting research and analysis of current events and COVID-19 response to identify strengths and areas for improvement in
other regions.
Updating and developing new programs to provide enhanced education on public health emergencies including pandemics.
Exploring course development opportunities in infection prevention and control for frontline responders in the hospital and in the
field.
Serving as a source of information for COVID-19 related concerns or questions regarding public health, emergency medical service
(EMS), public safety and healthcare response.
Local networking and pandemic response analysis for New York’s tri-state area, using first-person
experiences to highlight current trends.

                                      

The White House
On November 22, 2022, White House Press Secretary Karine Jean-Pierre, COVID-19 Response
Coordinator Dr. Ashish Jha, and Chief Medial Advisor Dr. Anthony Fauci provided a press briefing
regarding the importance of getting vaccinated prior to the holiday weekend.
https://www.whitehouse.gov/briefing-room/press-briefings/2022/11/22/press-briefing-by-press-

secretary-karine-jean-pierre-covid-19-response-coordinator-dr-ashish-jha-and-chief-medial-advisordr-anthony-fauci/
On November 22, 2022, Biden Administration Announces Six-Week Campaign to Get More
Americans their Updated COVID-19 Vaccine Before End of the Year- the Biden Administration is
announcing a six-week campaign through the end of the year urging Americans to get their
updated COVID-19 vaccine. With winter and holiday gatherings right around the corner, more
Americans getting their updated vaccine will help avoid thousands of preventable COVID-19
deaths. The six-week campaign will focus on reaching seniors and the communities that were
hardest hit by COVID-19 by making it even more convenient to get vaccinated and increasing
awareness through paid media.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/11/22/fact-sheet-bidenadministration-announces-six-week-campaign-to-get-more-americans-their-updated-covid-19vaccine-before-end-of-the-year/
The official website of the White House will deliver updated information as the country grapples
with converging crises. This will include actions to control the COVID-19 pandemic and monkeypox
and provide economic relief, tackle climate change, and advance racial equity and civil rights, as
well as immediate actions to reform our immigration system and restore America’s standing in the
world. This website will provide all information in one central location.
https://www.whitehouse.gov

COVID-19 Website
On March 30, 2022, Biden Administration Launched COVID.gov, a New One-Stop Shop Website
for Vaccines, Tests, Treatments, Masks, and the Latest COVID-19 Information- a new website was
launched in an effort to consolidate information for consumers.
https://www.whitehouse.gov/briefing-room/statements-releases/2022/03/30/fact-sheet-bidenadministration-launches-covid-gov-a-new-one-stop-shop-website-for-vaccines-tests-treatmentsmasks-and-the-latest-covid-19-information/

Health and Human Services (HHS)
On November 28, 2022, Biden Harris Administration Supports the World Health Organization
Renaming of Monkeypox to mpox- the Biden Harris Administration offered support for the World
Health Organization (WHO) announcement that it is renaming monkeypox disease to mpox. “We
welcome the change by the World Health Organization. We must do all we can to break down
barriers to public health, and reducing stigma associated with disease is one critical step in our
work to end mpox,” said U.S. Department of Health and Human Services (HHS) Secretary Xavier
Becerra.
https://www.hhs.gov/about/news/2022/11/28/biden-harris-administration-supports-the-world-healthorganization-renaming-of-monkeypox-to-mpox.html
On November 22, 2022, HHS Announces New $350 Million Initiative to Increase COVID-19
Vaccinations- the U.S. Department of Health and Human Services (HHS), through the Health
Resources and Services Administration (HRSA), announced a new $350 million initiative for HRSAsupported health centers to increase COVID-19 vaccines in their communities, with a specific focus
on underserved populations. This funding will support health centers administering updated
COVID-19 vaccines through mobile, drive-up, walk-up, or community-based vaccination events,
including working with community-based organizations, and other efforts to increase the
administration of COVID-19 vaccines.
https://www.hhs.gov/about/news/2022/11/22/hhs-announces-new-350-million-initiative-increasecovid-19-vaccinations.html
For the latest COVID-19 information from HHS
https://www.hhs.gov/about/news/coronavirus/index.html

National Institutes of Health (NIH)
On November 22, 2022, NIH established a website for self-reporting COVID-19 test resultsReporting a positive or negative test result just became easier through a new website from the
National Institutes of Health. MakeMyTestCount.org, developed through NIH’s Rapid Acceleration
of Diagnostics (RADx®) Tech program, allows users to anonymously report the results of any
brand of at-home COVID-19 test.
https://www.nih.gov/news-events/news-releases/nih-establishes-website-self-reporting-covid-19test-results
View the latest COVID-19 information from NIH.
https://www.nih.gov/coronavirus

Centers for Disease Control and Prevention (CDC)      
Monkeypox is a rare disease caused by infection with the monkeypox virus. Monkeypox virus is part
of the same family of viruses as variola virus, the virus that causes smallpox. Monkeypox symptoms
are like smallpox symptoms, but milder, and monkeypox is rarely fatal. Monkeypox is not related to

chickenpox.
For the latest CDC information including symptoms, testing, vaccines and prevention regarding
monkeypox, please visit
https://www.cdc.gov/poxvirus/monkeypox/
According to the CDC, as of November 28, 2022, there are 29,288 cases in the United States. For
the latest monkeypox cases in the United States, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/us-map.html
According to the CDC, as of November 28, 2022, there are 81,188 cases in the world. For the latest
global monkeypox cases, please visit:
https://www.cdc.gov/poxvirus/monkeypox/response/2022/world-map.html
On November 28, 2022, the CDC updated the monkeypox section regarding the latest information
on signs and symptoms, vaccines, prevention, sexual health, cases and data.
https://www.cdc.gov/poxvirus/monkeypox/index.html
CDC provides updated information about the variants in the United States- The emerging variants
CDC is closely monitoring have mutations in the virus genome that alter the characteristics and
cause the virus to act differently in ways that are significant to public health (e.g., causes more
severe disease, spreads more easily between humans, requires different treatments, changes the
effectiveness of current vaccines). It’s important to understand that genetic mutations are expected,
and some variants can spread and become predominant while others subside.
https://www.cdc.gov/coronavirus/2019-ncov/transmission/variant-cases.html
On November 22, 2022, the CDC released a study regarding Effectiveness of Bivalent mRNA
Vaccines in Preventing Symptomatic SARS-CoV-2 Infection — Increasing Community Access to
Testing Program, United States, September–November 2022- In this study of vaccine effectiveness
of the U.S.-authorized bivalent mRNA booster formulations, bivalent boosters provided significant
additional protection against symptomatic SARS-CoV-2 infection in persons who had previously
received 2, 3, or 4 monovalent vaccine doses. Due to waning immunity of monovalent doses, the
benefit of the bivalent booster increased with time since receipt of the most recent monovalent
vaccine dose.
https://www.cdc.gov/mmwr/volumes/71/wr/mm7148e1.htm?
s_cid=mm7148e1_x#:~:text=In%20this%20study%20of,recent%20monovalent%20vaccine%20dose.
CDC provides daily data tracker which has maps and charts tracking cases, deaths, and trends of
COVID-19 in the United States- updated daily by 8 p.m. ET.
https://covid.cdc.gov/covid-data-tracker/#datatracker-home
For the latest CDC information
https://www.cdc.gov/coronavirus/2019-ncov/cases-updates/index.html

United States Food and Drug Administration (FDA)
On November 22, 2022, the FDA issued an emergency use authorization (EUA) for the Lucira
COVID-19 and Flu Test for use in a point-of-care (POC) setting, following collaboration with the
National Institutes of Health (NIH) Independent Test Assessment Program (ITAP). “This
authorization demonstrates our continued commitment to expand the availability of multiplex tests for
COVID-19 and flu and provide a streamlined approach to developers to increase the availability of
these types of tests,” said Jeff Shuren, M.D., J.D., director of the FDA’s Center for Devices and
Radiological Health.
https://www.fda.gov/medical-devices/coronavirus-disease-2019-covid-19-emergency-useauthorizations-medical-devices/in-vitro-diagnostics-euas-molecular-diagnostic-tests-sars-cov-2
On November 22, 2022, 439 tests and sample collection devices are authorized by the FDA under
emergency use authorizations (EUAs). These include 300 molecular tests and sample collection
devices, 85 antibody and other immune response tests, 53 antigen tests, and 1 diagnostic breath
test. There are 78 molecular authorizations and 1 antibody authorization that can be used with
home-collected samples. There is 1 EUA for a molecular prescription at-home test, 2 EUAs for
antigen prescription at-home tests, 21 EUAs for antigen over-the-counter (OTC) at-home tests, and
4 for molecular OTC at-home tests. The FDA has authorized 37 antigen tests and 8 molecular tests
for serial screening programs. The FDA has also authorized 1162 revisions to EUA authorizations.
https://www.fda.gov/news-events/press-announcements/fda-roundup-november-22-2022
The FDA created a specific monkeypox response page which serves as a central source of
information regarding diagnostics, vaccines, and therapeutics. For the latest FDA information
regarding monkeypox, please visit
https://www.fda.gov/emergency-preparedness-and-response/mcm-issues/fda-monkeypox-response
For the latest overall FDA information about COVID-19.
https://www.fda.gov/emergency-preparedness-and-response/counterterrorism-and-emergingthreats/coronavirus-disease-2019-covid-19

Center for Medicare and Medicaid Services (CMS) +
On November 22, 2022, CMS Urges Timely Patient Access to COVID-19 Vaccines, Therapeuticsthe Centers for Medicare & Medicaid Services (CMS) issued new guidance that highlights the need
for health care providers and suppliers to ensure patients have access to the latest available COVID19 vaccines and therapeutics. In particular, CMS is reminding nursing homes that they are required
to offer the COVID-19 vaccines, including any updated COVID vaccines, to residents.
https://www.cms.gov/newsroom/news-alert/cms-urges-timely-patient-access-covid-19-vaccinestherapeutics

View the latest information from CMS
https://www.cms.gov/About-CMS/Agency-Information/Emergency/EPRO/CurrentEmergencies/Current-Emergencies-page

Vaccines
In this section, vaccine-related information from various sources will be collected, reviewed, and
tabulated here. As of July 19, 2022, the FDA has granted Emergency Use Authorization (EUA) to
Janssen/Johnson & Johnson for adults over 18 years and Novavax for adults over 18 years of age
and EUA for Moderna and Pfizer for children 6 months to five years. On August 26, 2022, the FDA
authorized the emergency use of Novavax COVID-19 Vaccine, Adjuvanted for the prevention of
Coronavirus Disease 2019 (COVID-19) caused by severe acute respiratory syndrome coronavirus 2
(SARS-CoV-2) in individuals 12 through 17 years of age. This authorization follows a rigorous
analysis and evaluation of the safety and effectiveness data conducted by the FDA. On August 23,
2021, the FDA granted full approval to Pfizer for adults. On January 31, 2022, the FDA granted full
approval to Moderna for adults. Now with two vaccines with full FDA approval and three vaccines
with EUA for adults and children, the goal is to vaccinate a larger number of persons in the coming
months throughout the United States. As additional vaccines are granted EUA, information for those
vaccines will also be included.
CDC created this section regarding COVID-19 vaccinations in the United States- CDC provides
overall U.S. COVID-19 Vaccine, deliveries and administration, maps, charts, and data updated daily
by 8 p.m. This section represents all vaccine partners including jurisdictional partner clinics, retail
pharmacies, long-term care facilities, Federal Emergency Management Agency and Health
Resources and Services Administration partner sites, and federal entity facilities.
https://covid.cdc.gov/covid-data-tracker/#vaccinations_vacc-total-admin-rate-total
The NYS DOH COVID-19 Vaccine Tracker Dashboard will update New Yorkers on the distribution of
the vaccine including the number of doses received by the state, a breakdown of first or second
doses, and the number of persons vaccinated with the first and second doses in each region.
https://covid19vaccine.health.ny.gov/covid-19-vaccine-tracker
The NYS DOH provides updated monkeypox information regarding signs and symptoms, cases,
vaccine, treatment and prevention at
https://health.ny.gov/diseases/communicable/zoonoses/monkeypox/
CDC created this section regarding the Johnson & Johnson’s Janssen vaccine to provide updated
relevant information including side effects and safety data, clinical trials demographic statistics, and
information on how the vaccine works.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/janssen.html
CDC created this section regarding the Moderna vaccine to provide updated relevant information
including side effects and safety data, clinical trials demographic statistics, and information on how
the vaccine works. As of January 31, 2022, the fully FDA approved Moderna vaccine will now be
known as SPIKEVAX for ages 6 months and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Moderna.html
CDC created this section regarding the Pfizer BioNTech vaccine to provide updated relevant
information including side effects and safety data, clinical trials demographic statistics, and
information on how the vaccine works. As of October 16, 2021, the fully FDA approved Pfizer
vaccine will now be known as COMIRNATY for ages 6 months and older.
https://www.cdc.gov/coronavirus/2019-ncov/vaccines/different-vaccines/Pfizer-BioNTech.html
HHS created this section to provide the latest information about COVID-19 vaccines.
https://www.hhs.gov/coronavirus/covid-19-vaccines/index.html
For NYC DOHMH updated guidance regarding COVID-19 vaccine
https://www1.nyc.gov/site/doh/covid/covid-19-vaccines.page
The Vaccine Finder is a one-stop site for New Yorkers to find their nearest COVID-19 vaccination
location. The Vaccine Finder can also provide New Yorkers with information to schedule vaccination
appointments.
https://vaccinefinder.nyc.gov/

Clinical Trials
To view the latest information on clinical trials regarding COVID-19
https://www.clinicaltrials.gov/ct2/results?recrs=&cond=Covid19&term=&cntry=&state=&city=&dist=

American Red Cross
https://www.redcrossblood.org/donate-blood/dlp/plasma-donations-from-recovered-covid-19patients.html

State Updates

New York State Department of Health (DOH)
On November 28, 2022, Governor Hochul updated New Yorkers on the state's progress combating COVID-19. "It is the
time of year when respiratory illnesses including COVID-19 spread quickly throughout our communities, and I urge New
Yorkers to take advantage of all available tools to keep themselves and their loved ones safe and healthy," Governor
Hochul said. "Stay up to date on vaccine doses, and test before gatherings or travel. If you test positive, talk to your doctor
about potential treatment options."
https://www.governor.ny.gov/news/governor-hochul-updates-new-yorkers-states-progress-combating-covid-19-391
For a list of COVID-19 positive cases by county in New York Statehttps://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
NYS DOH has created a dynamic COVID-19 Tracker which provides COVID-19 information regarding testing, cases,
percentages, and fatalities across New York State. It also breaks down cases by county.
https://covid19tracker.health.ny.gov/views/NYS-COVID19-Tracker/NYSDOHCOVID-19Tracker-Map?
%3Aembed=yes&%3Atoolbar=no&%3Atabs=n
For the latest COVID-19 information from NYS DOH
https://coronavirus.health.ny.gov/home
As of November 28, 2022, there are 4,141 cases of monkeypox in New York State. For the latest monkeypox information
including vaccines and provider information from NYS DOH, please visit:
https://www.health.ny.gov/diseases/communicable/zoonoses/monkeypox/

Local Updates
New York Blood Center (NYBC)
For the latest updated NYBC information about COVID-19:
https://nybc.org/covid-19/

New York City (NYC) Department of Health and Mental Hygiene (DOHMH)
New York City is currently the epicenter of the monkeypox outbreak in the United States. As of November 28, 2022, there are 3,771 cases of
monkeypox in New York City. For the latest information including cases, symptoms, testing, and vaccine information regarding monkeypox in New
York City, please visit
https://www1.nyc.gov/site/doh/health/health-topics/monkeypox.page
NYC DOHMH launched a new COVID-19 variants data page. The data on this page show how variants of the virus that causes COVID-19 are
spreading in NYC. Variants are versions of the virus with certain sets of mutations. Some variants may result in a COVID-19 infection that is easier to
spread, more severe or able to avoid antibodies from vaccines or previous infections.
https://www1.nyc.gov/site/doh/covid/covid-19-data-variants.page
For NYC DOHMH updated COVID-19 data page
https://www1.nyc.gov/site/doh/covid/covid-19-data.page

Westchester County Department of Health

For the latest breakdown of COVID-19 positive cases in Westchester County as of November 28, 2022,
https://wcgis.maps.arcgis.com/apps/dashboards/280339d96db14efd9cc304dba0f3a71d
For the latest COVID-19 information in Westchester including vaccines for children.
https://health.westchestergov.com/2019-novel-coronavirus
As of November 28, 2022, Westchester County has 93 cases of monkeypox. Monkeypox Vaccine Clinics on Mondays and Wednesdays at 134 Court
Street, White Plains. Appointments are required. People at higher risk for monkeypox infection may consider vaccination with the two-dose JYNNEOS
vaccine. In accordance with CDC guidance, this includes those who:
Had contact with someone who had a rash that looks like monkeypox or with someone who was diagnosed with confirmed or probable
monkeypox
Had skin-to-skin contact with someone in a social network experiencing monkeypox activity;
Traveled outside the United States to a country with confirmed cases of monkeypox or where monkeypox activity has been ongoing
Monkeypox Vaccine appointments are also available at:
- Westchester Medical Center, 15 Oval Connector, Valhalla, NY 10595
Monday through Friday from 9 am - 5 pm, appointment required.
Call (914) 326-2060 to schedule an appointment.
For more information regarding monkeypox in Westchester County, please visit
https://health.westchestergov.com/

Putnam County Department of Health
Breakdown of COVID -19 positive cases by towns in Putnam County as of November 18, 2022.
https://www.putnamcountyny.com/covid19/
As of November 21, 2022, there are 5 cases of monkeypox in Putnam County.
For the latest COVID-19 information
https://www.putnamcountyny.com/health/coronavirus/

Dutchess County Department of Health
Breakdown of positive cases in Dutchess County as of November 28, 2022.
https://www.dutchessny.gov/Departments/DBCH/covid-19-dashboard.htm
For the latest COVID-19 information:
https://www.dutchessny.gov/Departments/DBCH/2019-Novel-Coronavirus.htm
As of November 28, 2022, there are 10 cases of monkeypox in Dutchess County. For the latest information regarding monkeypox, please visit
https://www.dutchessny.gov/Departments/DBCH/dbch.htm

Orange County Department of Health
Updated COVID-19 dashboard for Orange County, NY as of November 28, 2022.
https://ocnygis.maps.arcgis.com/apps/dashboards/21de1fb5ce0c480f95dc0cf2b8b83b71
For the latest COVID-19 information
https://www.orangecountygov.com/1906/2019-Novel-Coronavirus-Information
As of November 28, 2022, there are 23 cases of monkeypox in Orange County. For more information regarding monkeypox, please visit
https://www.orangecountygov.com/149/Health

Rockland County Department of Health
Review Rockland County’s dashboard with the latest COVID-19 information regarding cases as of November 28, 2022.
https://www.arcgis.com/apps/dashboards/d074e0336e81449393a76d1768ceb096
For the latest COVID-19 information
https://rocklandgov.com/departments/health/coronavirus-covid-19/
As of November 28, 2022, there are 19 cases of monkeypox in Rockland County.
For more information regarding monkeypox, please visit Rockland County Health Department website
https://rocklandgov.com/departments/health/

Healthcare
For the latest COVID-19 information for healthcare facilities from the Greater New York Hospital Association that covers hospitals in the tri-state area.
https://www.gnyha.org/

   

Every effort is made to provide accurate and complete information in this newsletter. However, New York Medical College cannot guarantee that
there will be no errors. NYMC makes no claims, promises or guarantees about the accuracy, completeness, or adequacy of the contents of the
newsletters or the articles linked herein and further expressly disclaims liability for errors and omissions in the contents of this newsletter.
This newsletter is for informational purposes only; it does not constitute medical advice. Always seek the advice of your physician or other qualified
health provider with any questions you may have regarding a medical condition.

New York Medical College
Center for Disaster Medicine
7 Dana Road Suite 511
Valhalla, New York 10595
914-594-1750

https://www.nymc.edu/center-for-disaster-medicine/
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